Neovasc (TSX:NVCN) Other Operating Expense : C$0.14 Mil (TTM As of Dec. 2022)

View and export this data going back to 2001. Start your Free Trial

What is Neovasc Other Operating Expense?

Neovasc's Other Operating Expense for the three months ended in Dec. 2022 was C$0.02 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2022 was C$0.14 Mil.

Neovasc's quarterly Other Operating Expense declined from Jun. 2022 (C$0.04 Mil) to Sep. 2022 (C$0.02 Mil) and declined from Sep. 2022 (C$0.02 Mil) to Dec. 2022 (C$0.02 Mil).

Neovasc's annual Other Operating Expense declined from Dec. 2020 (C$0.76 Mil) to Dec. 2021 (C$0.47 Mil) and declined from Dec. 2021 (C$0.47 Mil) to Dec. 2022 (C$0.15 Mil).

Neovasc Other Operating Expense Historical Data

The historical data trend for Neovasc's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neovasc Other Operating Expense Chart

Neovasc Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Other Operating Expense

Get a 7-Day Free Trial

6.97

1.15

0.76

0.47

0.15

Neovasc Quarterly Data
	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22
Other Operating Expense	Get a 7-Day Free Trial															0.10	0.06	0.04	0.02	0.02

Neovasc Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.14 Mil.

Neovasc Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Neovasc's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Neovasc (TSX:NVCN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Neovasc Inc (TSX:NVCN) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

13562 Maycrest Way, Suite 5138, Richmond, BC, CAN, V6V 2J7

Website

https://www.neovasc.com

Neovasc Inc is a specialty medical device company. It develops, manufactures and markets products for the rapidly growing cardiovascular marketplace. Its products the Neovasc Reducer (Reducer), for the treatment of refractory angina, which is not currently commercially available in the United States and has been commercially available in Europe since 2015, and the Tiara, for the transcatheter treatment of mitral valve disease, which is under clinical investigation in the United States, Canada, Israel and Europe. The company earns revenue from one source, the Reducer.